Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma
Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clini...
Saved in:
| Published in | Nuclear medicine and molecular imaging Vol. 58; no. 4; pp. 237 - 245 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
Springer Nature Singapore
01.06.2024
Springer Nature B.V 대한핵의학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1869-3474 1869-3482 |
| DOI | 10.1007/s13139-024-00847-4 |
Cover
| Abstract | Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosis to mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specialized radiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization, cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to provide a recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice. |
|---|---|
| AbstractList | Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosis to mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specialized radiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization, cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to provide a recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice. Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosis to mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specialized radiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization, cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to provide a recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice.Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scans enable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosis to mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specialized radiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization, cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to provide a recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice. Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive gliomaevaluation, offering complementary insights to those gained through magnetic resonance imaging (MRI). PET/CT scansenable a multifaceted analysis of glioma biology, supporting clinical applications from grading and differential diagnosisto mapping the full extent of tumors and planning subsequent treatments and evaluations. With a broad array of specializedradiotracers, researchers and clinicians can now probe various biological characteristics of gliomas, such as glucose utilization,cellular proliferation, oxygen deficiency, amino acid trafficking, and reactive astrogliosis. This review aims to providea recent update on the application of versatile PET/CT radiotracers in glioma research and clinical practice. KCI Citation Count: 9 |
| Author | Kim, Sun Jung Yun, Mijin Hwang, Hee Sung Kim, Dongwoo Lee, Suk-Hyun |
| Author_xml | – sequence: 1 givenname: Dongwoo surname: Kim fullname: Kim, Dongwoo organization: Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine – sequence: 2 givenname: Suk-Hyun surname: Lee fullname: Lee, Suk-Hyun organization: Department of Radiology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine – sequence: 3 givenname: Hee Sung surname: Hwang fullname: Hwang, Hee Sung organization: Department of Nuclear Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine – sequence: 4 givenname: Sun Jung surname: Kim fullname: Kim, Sun Jung organization: Department of Nuclear Medicine, National Health Insurance Service Ilsan Hospital – sequence: 5 givenname: Mijin surname: Yun fullname: Yun, Mijin email: yunmijin@yuhs.ac organization: Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38932755$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003107671$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp9kUtr3DAUhUVJaR7NH-iiGLopATe6eljSqglDmg4EWobJWsi2PFViS1PJU-i_rzxO0jaLaCOBvnN0rs4xOvDBW4TeAf4EGIvzBBSoKjFhJcaSiZK9QkcgK1VSJsnB01mwQ3Sa0h3OixKFqXiDDqlUlAjOj9DFyjbWj8XttjWjLYIvvl-tzxfrYmVaF8ZoGhtT0YVYLAezcX5TLGy0dTR9cd27MJi36HVn-mRPH_YTdPvlar34Wt58u14uLm_KhgMey1oyK1VDJKlEQ9oWqo4RxgwnRLWdqjnDXSWUskox23HOAOqqkkSCtFK0hp6gs9nXx07fN04H4_b7Juj7qC9X66UGzKXAQDP8eYa3u3qw7TRhTqy30Q0m_t5L_7_x7kc2-qUBQFUcIDt8fHCI4efOplEPLjW27423YZc0xSJn41hNj314ht6FXfT5MyYKlBQS80y9_zfSU5bHKjIgZ6CJIaVoO9240YwuTAldn4fTU_F6Ll7n4vW-eM2ylDyTPrq_KKKzKGXYb2z8G_sF1R9C5bvy |
| CitedBy_id | crossref_primary_10_1007_s00259_024_06964_8 crossref_primary_10_1007_s13139_024_00865_2 crossref_primary_10_1007_s00259_024_06935_z |
| Cites_doi | 10.1212/WNL.32.12.1323 10.2214/AJR.07.2660 10.1097/MD.0000000000002583 10.1371/journal.pone.0111598 10.1016/0883-2889(86)90079-1 10.1007/s00259-012-2275-9 10.1007/s00259-008-0981-0 10.1093/neuonc/nov189 10.1007/s11307-008-0152-5 10.1089/ars.2013.5378 10.1186/s40824-023-00408-4 10.1002/syn.20899 10.1007/s00259-022-05817-6 10.1016/j.clon.2014.02.002 10.1097/RLU.0000000000002006 10.1007/s00259-005-0047-5 10.1016/0020-708X(82)90003-5 10.3390/ijms22115518 10.1016/S0303-8467(01)00197-4 10.1038/bjc.1981.79 10.1097/RLU.0b013e3181becfe0 10.1016/S0360-3016(00)01482-6 10.1093/brain/awad037 10.2967/jnumed.107.046615 10.1093/neuonc/nos259 10.1186/s13550-020-00645-x 10.1111/bpa.12307 10.2967/jnumed.111.102533 10.1093/neuonc/nov148 10.1038/jcbfm.2011.84 10.1038/s41593-020-00735-y 10.1016/S0021-9258(19)38247-X 10.5732/cjc.013.10217 10.1007/s00259-021-05603-w 10.3413/Nukmed-0662-14-04 10.2310/7290.2011.00014 10.21037/qims-22-1340 10.1016/S0969-8051(00)00177-3 10.1007/s00401-016-1545-1 10.1111/j.1471-4159.1969.tb06854.x 10.1053/j.semnuclmed.2007.08.001 10.1097/00004647-199805000-00005 10.1007/s00401-008-0455-2 10.1093/neuonc/noad243 10.2967/jnumed.112.104992 10.1007/s00259-018-3948-9 10.1016/j.celrep.2020.107975 10.1371/journal.pone.0095830 10.3389/fneur.2021.740280 10.1046/j.1471-4159.1995.64062773.x 10.1007/s00259-019-04337-0 10.1007/s13139-020-00672-5 10.1016/j.surge.2013.12.001 10.1038/jcbfm.1993.110 10.3390/ijms20194669 10.1016/j.cell.2014.11.025 10.3390/cancers12071977 10.1007/s11060-012-0986-1 10.1038/nm.3639 10.1093/neuonc/noab106 10.1097/RLU.0000000000004341 10.3390/cancers13194777 10.1007/s00259-001-0690-4 10.2967/jnumed.120.249524 10.1016/j.jocn.2009.05.009 10.1126/science.1173362 10.1007/s00259-005-0023-0 10.2967/jnumed.112.105544 10.1177/0271678X20911469 10.1007/s00259-018-4207-9 10.1016/S1474-4422(06)70597-X 10.1523/JNEUROSCI.18-14-05225.1998 10.1056/NEJM197204272861707 10.3390/jcm8081088 10.1259/bjr.20170426 10.1111/j.1471-4159.2004.02935.x 10.3389/fneur.2021.671867 10.2967/jnumed.112.112201 10.1093/neuonc/noac040 10.1016/j.nucmedbio.2007.11.004 10.1016/S0891-5849(02)00815-8 10.1007/s00259-012-2295-5 10.3390/ijms23126787 10.1007/s00259-003-1404-x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024. corrected publication 2024 The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. The Author(s) 2024. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024, corrected publication 2024 2024 |
| Copyright_xml | – notice: The Author(s) 2024. corrected publication 2024 – notice: The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: The Author(s) 2024. corrected publication 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024, corrected publication 2024 2024 |
| DBID | C6C AAYXX CITATION NPM NAPCQ 7X8 5PM ACYCR |
| DOI | 10.1007/s13139-024-00847-4 |
| DatabaseName | Springer Nature OA Free Journals CrossRef PubMed Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
| DatabaseTitle | CrossRef PubMed Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitleList | PubMed Nursing & Allied Health Premium CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1869-3482 |
| EndPage | 245 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10587013 PMC11196511 38932755 10_1007_s13139_024_00847_4 |
| Genre | Journal Article Review |
| GroupedDBID | --- -EM .UV 06D 0R~ 0VY 1N0 203 29~ 2KG 2VQ 30V 4.4 406 408 40D 67Z 8JR 96X 9ZL AAAVM AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH AAZMS ABAKF ABDZT ABECU ABFTV ABJNI ABJOX ABKCH ABMQK ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACKNC ACMDZ ACMLO ACOKC ACPIV ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGNC AEJHL AEJRE AEMSY AEOHA AEPYU AESKC AETCA AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALFXC ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF AMYQR ANMIH AOCGG AOIJS ASPBG AVWKF AXYYD AZFZN BAWUL BGNMA C6C CSCUP DDRTE DIK DNIVK DPUIP EBLON EBS EF. EIOEI EJD ESBYG F5P FEDTE FERAY FIGPU FINBP FNLPD FRRFC FSGXE FYJPI GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HMJXF HRMNR HVGLF HYE HZ~ I0C IKXTQ IWAJR IXD J-C J0Z JBSCW JZLTJ KOV LLZTM M4Y NPVJJ NQJWS NU0 O9- O9J OK1 P9S PT4 R9I RLLFE ROL RPM RSV S27 S37 S3B SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 T13 TSG U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 Z45 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ NPM NAPCQ 7X8 5PM ACYCR |
| ID | FETCH-LOGICAL-c510t-b84e89c28267c2dd16f4244a5229df9b540f6799e994ef55411b6682818e87da3 |
| IEDL.DBID | AGYKE |
| ISSN | 1869-3474 |
| IngestDate | Sat Sep 06 06:29:09 EDT 2025 Thu Aug 21 18:34:50 EDT 2025 Fri Jul 11 15:26:28 EDT 2025 Wed Sep 03 00:18:58 EDT 2025 Mon Jul 21 06:02:39 EDT 2025 Thu Apr 24 22:53:17 EDT 2025 Tue Jul 01 01:05:52 EDT 2025 Fri Feb 21 02:39:55 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | C-acetate F-FLT Amino acid radiotracer F-FMISO Glioma F-FDG 18F-FLT 11C-acetate 18F-FDG 18F-FMISO |
| Language | English |
| License | The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c510t-b84e89c28267c2dd16f4244a5229df9b540f6799e994ef55411b6682818e87da3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/s13139-024-00847-4 |
| PMID | 38932755 |
| PQID | 3071987805 |
| PQPubID | 2044329 |
| PageCount | 9 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10587013 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11196511 proquest_miscellaneous_3072815093 proquest_journals_3071987805 pubmed_primary_38932755 crossref_citationtrail_10_1007_s13139_024_00847_4 crossref_primary_10_1007_s13139_024_00847_4 springer_journals_10_1007_s13139_024_00847_4 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-01 |
| PublicationDateYYYYMMDD | 2024-06-01 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore – name: Germany – name: Heidelberg |
| PublicationTitle | Nuclear medicine and molecular imaging |
| PublicationTitleAbbrev | Nucl Med Mol Imaging |
| PublicationTitleAlternate | Nucl Med Mol Imaging |
| PublicationYear | 2024 |
| Publisher | Springer Nature Singapore Springer Nature B.V 대한핵의학회 |
| Publisher_xml | – name: Springer Nature Singapore – name: Springer Nature B.V – name: 대한핵의학회 |
| References | CuiMZorrilla-VelozRIHuJGuanBMaXDiagnostic accuracy of PET for differentiating true glioma progression from post treatment-related changes: a systematic review and meta-analysisFront Neurol20211234093419817315710.3389/fneur.2021.671867 IsselbacherKJSugar and amino acid transport by cells in culture–differences between normal and malignant cellsN Engl J Med19722869299331:STN:280:DyaE387ktVCitw%3D%3D433531710.1056/NEJM197204272861707 ChungJKKimYKKimSKLeeYJPaekSYeoJSUsefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PETEur J Nucl Med Mol Imaging2002291761821:CAS:528:DC%2BD38XnvFSmtg%3D%3D1192637910.1007/s00259-001-0690-4 NicklasWJClarkeDDDecarboxylation studies of glutamate, glutamine, and aspartate from brain labelled with [1-14C]acetate, L-[U-14C]-aspartate, and L-[U-14C]glutamateJ Neurochem1969165495581:CAS:528:DyaF1MXktVWgtb0%3D576821110.1111/j.1471-4159.1969.tb06854.x WaniewskiRAMartinDLPreferential utilization of acetate by astrocytes is attributable to transportJ Neurosci199818522552331:CAS:528:DyaK1cXksFarsbY%3D9651205679349010.1523/JNEUROSCI.18-14-05225.1998 Mattoli MV, Trevisi G, Scolozzi V, Capotosti A, Cocciolillo F, Marini I, et al. Dynamic (11)C-methionine PET-CT: prognostic factors for disease progression and survival in patients with suspected glioma recurrence. Cancers (Basel). 2021;13:4777. OmuroAMLeiteCCMokhtariKDelattreJYPitfalls in the diagnosis of brain tumoursLancet Neurol200659379481705266110.1016/S1474-4422(06)70597-X TakataKKatoHShimosegawaEOkunoTKodaTSugimotoT11C-Acetate PET imaging in patients with multiple sclerosisPLoS ONE2014925369426421972510.1371/journal.pone.0111598 TsuchidaTTakeuchiHOkazawaHTsujikawaTFujibayashiYGrading of brain glioma with 1–11C-acetate PET: comparison with 18F-FDG PETNucl Med Biol2008351711761:CAS:528:DC%2BD1cXhsl2hurw%3D1831282610.1016/j.nucmedbio.2007.11.004 NinattiGSolliniMBonoBGozziNFedorovDAntunovicLPreoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomasNeuro Oncol202224154615561:CAS:528:DC%2BB3sXlsVGrtr4%3D35171292943550410.1093/neuonc/noac040 EidelbergDTakikawaSDhawanVChalyTRobesonWDahlRStriatal 18F-dopa uptake: absence of an aging effectJ Cereb Blood Flow Metab1993138818881:CAS:528:DyaK2cXhtVSkurs%3D836029410.1038/jcbfm.1993.110 YoulandRSKitangeGJPetersonTEPafundiDHRamiscalJAPokornyJLThe role of LAT1 in (18)F-DOPA uptake in malignant gliomasJ Neurooncol201311111181:CAS:528:DC%2BC38XhvFSgtLjP2308643110.1007/s11060-012-0986-1 ChenJRYaoYXuHZQinZYIsocitrate dehydrogenase (IDH)1/2 mutations as prognostic markers in patients with glioblastomasMedicine (Baltimore)2016951:CAS:528:DC%2BC28XktVOiu78%3D2694534910.1097/MD.0000000000002583 MiyagawaTOkuTUeharaHDesaiRBeattieBTjuvajevJ“Facilitated” amino acid transport is upregulated in brain tumorsJ Cereb Blood Flow Metab1998185005091:CAS:528:DyaK1cXjsVWitrg%3D959184210.1097/00004647-199805000-00005 Reuss AM, Groos D, Buchfelder M, Savaskan N. The acidic brain-glycolytic switch in the microenvironment of malignant glioma. Int J Mol Sci. 2021;22:5518. GlaudemansAWEntingRHHeestersMADierckxRAvan RheenenRWWalenkampAMValue of 11C-methionine PET in imaging brain tumours and metastasesEur J Nucl Med Mol Imaging2013406156351:CAS:528:DC%2BC3sXjslOgsbs%3D2323250510.1007/s00259-012-2295-5 DiepYNParkHJKwonJHTranMKoHYJoHAstrocytic scar restricting glioblastoma via glutamate-MAO-B activity in glioblastoma-microglia assembloidBiomater Res202327711:CAS:528:DC%2BB3sXhsFKqu7rJ374689611035502910.1186/s40824-023-00408-4 BrownJMTherapeutic targets in radiotherapyInt J Radiat Oncol Biol Phys2001493193261:STN:280:DC%2BD3M7kvFGlsw%3D%3D1117312410.1016/S0360-3016(00)01482-6 MasuiKCaveneeWKMischelPSmTORC2 and metabolic reprogramming in GBM: at the interface of genetics and environmentBrain Pathol2015257557591:CAS:528:DC%2BC2MXhvVSlsLbM26526943463601610.1111/bpa.12307 WesterHJHerzMWeberWHeissPSenekowitsch-SchmidtkeRSchwaigerMSynthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imagingJ Nucl Med1999402052121:CAS:528:DyaK1MXos1aitA%3D%3D9935078 VesselleHGriersonJMuziMPugsleyJMSchmidtRARabinowitzPIn vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumorsClin Cancer Res20028331533231:CAS:528:DC%2BD38XpsVCgtr0%3D12429617 GalldiksNKrachtLWDunklVUllrichRTVollmarSJacobsAHImaging of non- or very subtle contrast-enhancing malignant gliomas with [(1)(1)C]-methionine positron emission tomographyMol Imaging2011104534591:CAS:528:DC%2BC38XitlGnsrg%3D2220153610.2310/7290.2011.00014 NagashimaGSuzukiRAsaiJFujimotoTImmunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma casesClin Neurol Neurosurg20021041251311193204210.1016/S0303-8467(01)00197-4 OuyangZQZhengGRDuanXRZhangXRKeTFBaoSSDiagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysisQuant Imaging Med Surg20231349434959375810481042338210.21037/qims-22-1340 Di ChiroGDeLaPazRLBrooksRASokoloffLKornblithPLSmithBHGlucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomographyNeurology19823213231329698304410.1212/WNL.32.12.1323 MashimoTPichumaniKVemireddyVHatanpaaKJSinghDKSirasanagandlaSAcetate is a bioenergetic substrate for human glioblastoma and brain metastasesCell2014159160316141:CAS:528:DC%2BC2MXnslKqug%3D%3D25525878437460210.1016/j.cell.2014.11.025 DhermainFRadiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approachesChin J Cancer20143316241:CAS:528:DC%2BC2cXhsFakurnE24384237390508610.5732/cjc.013.10217 HoCLYuSCYeungDW11C-Acetate PET imaging in hepatocellular carcinoma and other liver massesJ Nucl Med20034421322112571212 Hirata K, Yamaguchi S, Shiga T, Kuge Y, Tamaki N. The roles of hypoxia imaging using (18)F-fluoromisonidazole positron emission tomography in glioma treatment. J Clin Med. 2019;8:1088. ColletSGuillamoJSBerroDHChakhoyanAConstansJMLechapt-ZalcmanESimultaneous mapping of vasculature, hypoxia, and proliferation using dynamic susceptibility contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastomaJ Nucl Med202162134913561:CAS:528:DC%2BB3MXisFamurfE34016725872490310.2967/jnumed.120.249524 JagerPLVaalburgWPruimJde VriesEGLangenKJPiersDARadiolabeled amino acids: basic aspects and clinical applications in oncologyJ Nucl Med2001424324451:CAS:528:DC%2BD3MXmvFOqt7k%3D11337520 TripathiMSharmaRD'SouzaMJaiminiAPanwarPVarshneyRComparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomasClin Nucl Med2009348788832013982110.1097/RLU.0b013e3181becfe0 SmithTAThe rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporationNucl Med Biol200128141:CAS:528:DC%2BD3MXht1yjs7s%3D1118255810.1016/S0969-8051(00)00177-3 StoberBTanaseUHerzMSeidlCSchwaigerMSenekowitsch-SchmidtkeRDifferentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cellsEur J Nucl Med Mol Imaging2006339329391660434610.1007/s00259-005-0047-5 DunetVPomoniAHottingerANicod-LalondeMPriorJOPerformance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysisNeuro Oncol2016184264341:CAS:528:DC%2BC1cXptVKntg%3D%3D2624379110.1093/neuonc/nov148 HasselBSonnewaldUFonnumFGlial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic studyJ Neurochem199564277327821:CAS:528:DyaK2MXlsl2lt7s%3D776005810.1046/j.1471-4159.1995.64062773.x BarajasRFJrPampaloniMHClarkeJLSeoYSavicDHawkinsRAAssessing biological response to bevacizumab using 18F-fluoromisonidazole PET/MR imaging in a patient with recurrent anaplastic astrocytomaCase Rep Radiol20152015257931364352456 LouisDNPerryAWesselingPBratDJCreeIAFigarella-BrangerDThe 2021 WHO classification of tumors of the central nervous system: a summaryNeuro Oncol202123123112511:CAS:528:DC%2BB3MXisFSht73J34185076832801310.1093/neuonc/noab106 MatsubaraKWatabeHKumakuraYHayashiTEndresCJMinatoKSensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [(1)(8)F]FDOPA PET by a model with detailed dopamine pathwaySynapse2011657517621:CAS:528:DC%2BC3MXmvFWhtrk%3D2119022010.1002/syn.20899 CruzNFLasaterAZielkeHRDienelGAActivation of astrocytes in brain of conscious rats during acoustic stimulation: acetate utilization in working brainJ Neurochem2005929349471:CAS:528:DC%2BD2MXhs1Kqtbs%3D1568649610.1111/j.1471-4159.2004.02935.x KatoHOkunoTIsohashiKKodaTShimizuMMochizukiHAstrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PETJ Cereb Blood Flow Metab2021413693791:CAS:528:DC%2BB3MXhtlOlu70%3D3216901310.1177/0271678X20911469 SinghalTNarayananTKJacobsMPBalCMantilJC11C-Methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRIJ Nucl Med201253170917152305553410.2967/jnumed.111.102533 KimDChunJHKimSHMoonJHKangSGChangJHRe-evaluation of the diagnostic performance of (11)C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomasEur J Nucl Med Mol Imaging201946167816841:CAS:528:DC%2BC1MXhtFert7vI3110200110.1007/s00259-019-04337-0 LiuRSChangCPChuLSChuYKHsiehHJChangCWPET imaging of brain astrocytoma with 1–11C-acetateEur J Nucl Med Mol Imaging2006334204271640459610.1007/s00259-005-0023-0 HammondEMAsselinMCForsterDO'ConnorJPSenraJMWilliamsKJThe meaning, measurement and modification of hypoxia in the laboratory and the clinicClin Oncol (R Coll Radiol)2014262772881:STN:280 G Nagashima (847_CR63) 2002; 104 847_CR44 EW Lau (847_CR31) 2010; 17 A Salskov (847_CR81) 2007; 37 J Balss (847_CR23) 2008; 116 NL Jansen (847_CR49) 2012; 14 SM Lee (847_CR21) 2002; 32 AM Omuro (847_CR17) 2006; 5 D Kim (847_CR50) 2019; 46 ZQ Ouyang (847_CR11) 2023; 13 JY Heo (847_CR61) 2020; 30 JD Chapman (847_CR93) 1981; 43 JM Johnson (847_CR20) 2021; 12 T Singhal (847_CR4) 2012; 53 847_CR36 A Shinomiya (847_CR86) 2013; 40 B Stober (847_CR42) 2006; 33 AK Demetriades (847_CR18) 2014; 12 H Kato (847_CR66) 2021; 41 H Chun (847_CR60) 2020; 23 E Ferdova (847_CR88) 2015; 35 RF Barajas Jr (847_CR98) 2015; 2015 PJ Pollard (847_CR22) 2009; 324 N Galldiks (847_CR34) 2011; 10 A Falk Delgado (847_CR35) 2018; 91 V Dunet (847_CR43) 2016; 18 YN Diep (847_CR79) 2023; 27 H Barthel (847_CR80) 2003; 63 847_CR1 D Salber (847_CR41) 2007; 48 E Guedj (847_CR14) 2022; 49 T Zaragori (847_CR48) 2020; 10 RA Waniewski (847_CR54) 1998; 18 P Heiss (847_CR39) 1999; 40 PL Jager (847_CR25) 2001; 42 JR Chen (847_CR24) 2016; 95 N Oyama (847_CR67) 2002; 43 MH Nam (847_CR62) 2020; 32 WJ Nicklas (847_CR53) 1969; 16 D Kim (847_CR8) 2018; 43 M Kinoshita (847_CR29) 2012; 53 847_CR5 EM Hammond (847_CR92) 2014; 26 PA Jerabek (847_CR94) 1986; 37 MT Wyss (847_CR56) 2011; 31 JM Brown (847_CR90) 2001; 49 K Matsubara (847_CR45) 2011; 65 I Law (847_CR12) 2019; 46 S Kim (847_CR75) 2018; 45 MR Ponisio (847_CR51) 2020; 7 AK Bag (847_CR37) 2022; 63 DN Louis (847_CR3) 2021; 23 T Mashimo (847_CR70) 2014; 159 S Collet (847_CR96) 2021; 62 G Ninatti (847_CR38) 2022; 24 D Kim (847_CR76) 2020; 54 W Chen (847_CR30) 2006; 47 RS Liu (847_CR72) 2006; 33 847_CR77 Y Yamamoto (847_CR73) 2008; 10 B Hassel (847_CR58) 1995; 64 DN Louis (847_CR2) 2016; 131 G Di Chiro (847_CR15) 1982; 32 M Nowosielski (847_CR87) 2014; 9 JC Walsh (847_CR89) 2014; 21 AW Glaudemans (847_CR33) 2013; 40 RS Youland (847_CR47) 2013; 111 T Miyagawa (847_CR28) 1998; 18 TA Smith (847_CR16) 2001; 28 N Oyama (847_CR68) 2009; 36 M Tripathi (847_CR85) 2009; 34 T Gronroos (847_CR95) 2004; 31 NF Cruz (847_CR55) 2005; 92 D Eidelberg (847_CR46) 1993; 13 S Jo (847_CR59) 2014; 20 K Masui (847_CR71) 2015; 25 MH Nam (847_CR64) 2023; 146 OS Tehrani (847_CR83) 2013; 54 KJ Isselbacher (847_CR26) 1972; 286 K Takata (847_CR65) 2014; 9 HJ Wester (847_CR40) 1999; 40 T Tsuchida (847_CR74) 2008; 35 847_CR19 VW Pike (847_CR52) 1982; 33 D Kim (847_CR78) 2022; 47 847_CR10 847_CR97 A Piccardo (847_CR13) 2022; 49 N Kosaka (847_CR7) 2008; 190 M Cui (847_CR9) 2021; 12 CL Ho (847_CR69) 2003; 44 847_CR91 AJ Idema (847_CR82) 2012; 53 S Cerdan (847_CR57) 1990; 265 JK Chung (847_CR32) 2002; 29 H Busch (847_CR27) 1959; 19 H Vesselle (847_CR84) 2002; 8 F Dhermain (847_CR6) 2014; 33 39881977 - Nucl Med Mol Imaging. 2025 Feb;59(1):91. doi: 10.1007/s13139-024-00879-w |
| References_xml | – reference: WaniewskiRAMartinDLPreferential utilization of acetate by astrocytes is attributable to transportJ Neurosci199818522552331:CAS:528:DyaK1cXksFarsbY%3D9651205679349010.1523/JNEUROSCI.18-14-05225.1998 – reference: KatoHOkunoTIsohashiKKodaTShimizuMMochizukiHAstrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PETJ Cereb Blood Flow Metab2021413693791:CAS:528:DC%2BB3MXhtlOlu70%3D3216901310.1177/0271678X20911469 – reference: PollardPJRatcliffePJCancer. Puzzling patterns of predispositionScience20093241921941:CAS:528:DC%2BD1MXkvFyhsrY%3D1935957310.1126/science.1173362 – reference: IsselbacherKJSugar and amino acid transport by cells in culture–differences between normal and malignant cellsN Engl J Med19722869299331:STN:280:DyaE387ktVCitw%3D%3D433531710.1056/NEJM197204272861707 – reference: DunetVPomoniAHottingerANicod-LalondeMPriorJOPerformance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysisNeuro Oncol2016184264341:CAS:528:DC%2BC1cXptVKntg%3D%3D2624379110.1093/neuonc/nov148 – reference: ChunHImHKangYJKimYShinJHWonWSevere reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H(2)O(2)(-) productionNat Neurosci202023155515661:CAS:528:DC%2BB3cXitlGjsLrE3319989610.1038/s41593-020-00735-y – reference: TsuchidaTTakeuchiHOkazawaHTsujikawaTFujibayashiYGrading of brain glioma with 1–11C-acetate PET: comparison with 18F-FDG PETNucl Med Biol2008351711761:CAS:528:DC%2BD1cXhsl2hurw%3D1831282610.1016/j.nucmedbio.2007.11.004 – reference: Mattoli MV, Trevisi G, Scolozzi V, Capotosti A, Cocciolillo F, Marini I, et al. Dynamic (11)C-methionine PET-CT: prognostic factors for disease progression and survival in patients with suspected glioma recurrence. Cancers (Basel). 2021;13:4777. – reference: Treglia G, Muoio B, Trevisi G, Mattoli MV, Albano D, Bertagna F, et al. Diagnostic performance and prognostic value of PET/CT with different tracers for brain tumors: a systematic review of published meta-analyses. Int J Mol Sci. 2019;20:4669. – reference: NicklasWJClarkeDDDecarboxylation studies of glutamate, glutamine, and aspartate from brain labelled with [1-14C]acetate, L-[U-14C]-aspartate, and L-[U-14C]glutamateJ Neurochem1969165495581:CAS:528:DyaF1MXktVWgtb0%3D576821110.1111/j.1471-4159.1969.tb06854.x – reference: IdemaAJHoffmannALBoogaartsHDTroostEGWesselingPHeerschapA3′-Deoxy-3′-18F-fluorothymidine PET-derived proliferative volume predicts overall survival in high-grade glioma patientsJ Nucl Med201253190419101:CAS:528:DC%2BC3sXktFKrug%3D%3D2307711210.2967/jnumed.112.105544 – reference: HasselBSonnewaldUFonnumFGlial-neuronal interactions as studied by cerebral metabolism of [2-13C]acetate and [1-13C]glucose: an ex vivo 13C NMR spectroscopic studyJ Neurochem199564277327821:CAS:528:DyaK2MXlsl2lt7s%3D776005810.1046/j.1471-4159.1995.64062773.x – reference: HeissPMayerSHerzMWesterHJSchwaigerMSenekowitsch-SchmidtkeRInvestigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivoJ Nucl Med199940136713731:CAS:528:DyaK1MXlslSktrY%3D10450690 – reference: TehraniOSShieldsAFPET imaging of proliferation with pyrimidinesJ Nucl Med2013549039121:CAS:528:DC%2BC3sXpvFeitr8%3D2367457610.2967/jnumed.112.112201 – reference: PonisioMRMcConathyJEDahiyaSMMiller-ThomasMMRichKMSalterADynamic (18)F-FDOPA-PET/MRI for the preoperative evaluation of gliomas: correlation with stereotactic histopathologyNeurooncol Pract20207656667333126797716181 – reference: NamMHChoJKwonDHParkJYWooJLeeJMExcessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery after subcortical strokeCell Rep2020321:CAS:528:DC%2BB3cXhsVyltL%2FE3269800910.1016/j.celrep.2020.107975 – reference: Kim D, Ko HY, Lee S, Lee YH, Ryu S, Kim SY, et al. Glucose loading enhances the value of (18)F-FDG PET/CT for the characterization and delineation of cerebral gliomas. Cancers (Basel). 2020;12:1977. – reference: JansenNLSchwartzCGrauteVEigenbrodSLutzJEgenspergerRPrediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomasNeuro Oncol201214147314801:CAS:528:DC%2BC38XhslWktL%2FJ23090986349901510.1093/neuonc/nos259 – reference: DiepYNParkHJKwonJHTranMKoHYJoHAstrocytic scar restricting glioblastoma via glutamate-MAO-B activity in glioblastoma-microglia assembloidBiomater Res202327711:CAS:528:DC%2BB3sXhsFKqu7rJ374689611035502910.1186/s40824-023-00408-4 – reference: Heiss WD. PET in gliomas. Overview of current studies. Nuklearmedizin. 2014;53:163–71; quiz N32. – reference: NinattiGSolliniMBonoBGozziNFedorovDAntunovicLPreoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomasNeuro Oncol202224154615561:CAS:528:DC%2BB3sXlsVGrtr4%3D35171292943550410.1093/neuonc/noac040 – reference: CerdanSKunneckeBSeeligJCerebral metabolism of [1,2–13C2]acetate as detected by in vivo and in vitro 13C NMRJ Biol Chem199026512916129261:CAS:528:DyaK3cXkvFGhsbk%3D197393110.1016/S0021-9258(19)38247-X – reference: CuiMZorrilla-VelozRIHuJGuanBMaXDiagnostic accuracy of PET for differentiating true glioma progression from post treatment-related changes: a systematic review and meta-analysisFront Neurol20211234093419817315710.3389/fneur.2021.671867 – reference: KimDKimSKimSHChangJHYunMPrediction of overall survival based on isocitrate dehydrogenase 1 mutation and 18F-FDG uptake on PET/CT in patients with cerebral gliomasClin Nucl Med2018433113162948545010.1097/RLU.0000000000002006 – reference: DhermainFRadiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approachesChin J Cancer20143316241:CAS:528:DC%2BC2cXhsFakurnE24384237390508610.5732/cjc.013.10217 – reference: BalssJMeyerJMuellerWKorshunovAHartmannCvon DeimlingAAnalysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathol20081165976021:CAS:528:DC%2BD1cXhtlyhsbfN1898536310.1007/s00401-008-0455-2 – reference: OyamaNOkazawaHKusukawaNKanedaTMiwaYAkinoH11C-Acetate PET imaging for renal cell carcinomaEur J Nucl Med Mol Imaging2009364224271901852910.1007/s00259-008-0981-0 – reference: LeeSMKohHJParkDCSongBJHuhTLParkJWCytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cellsFree Radic Biol Med200232118511961:CAS:528:DC%2BD38XjvVehu7g%3D1203190210.1016/S0891-5849(02)00815-8 – reference: WyssMTMagistrettiPJBuckAWeberBLabeled acetate as a marker of astrocytic metabolismJ Cereb Blood Flow Metab201131166816741:CAS:528:DC%2BC3MXps1Omt7Y%3D21654698317095510.1038/jcbfm.2011.84 – reference: SalskovATammisettiVSGriersonJVesselleHFLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3′-deoxy-3′-[18F]fluorothymidineSemin Nucl Med2007374294391792035010.1053/j.semnuclmed.2007.08.001 – reference: GalldiksNKrachtLWDunklVUllrichRTVollmarSJacobsAHImaging of non- or very subtle contrast-enhancing malignant gliomas with [(1)(1)C]-methionine positron emission tomographyMol Imaging2011104534591:CAS:528:DC%2BC38XitlGnsrg%3D2220153610.2310/7290.2011.00014 – reference: KimDChunJHKimSHMoonJHKangSGChangJHRe-evaluation of the diagnostic performance of (11)C-methionine PET/CT according to the 2016 WHO classification of cerebral gliomasEur J Nucl Med Mol Imaging201946167816841:CAS:528:DC%2BC1MXhtFert7vI3110200110.1007/s00259-019-04337-0 – reference: OuyangZQZhengGRDuanXRZhangXRKeTFBaoSSDiagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysisQuant Imaging Med Surg20231349434959375810481042338210.21037/qims-22-1340 – reference: KosakaNTsuchidaTUematsuHKimuraHOkazawaHItohH18F-FDG PET of common enhancing malignant brain tumorsAJR Am J Roentgenol2008190W365W3691849287910.2214/AJR.07.2660 – reference: NagashimaGSuzukiRAsaiJFujimotoTImmunohistochemical analysis of reactive astrocytes around glioblastoma: an immunohistochemical study of postmortem glioblastoma casesClin Neurol Neurosurg20021041251311193204210.1016/S0303-8467(01)00197-4 – reference: Kim D, Ko HY, Chung JI, Park YM, Lee S, Kim SY, et al. Visualizing cancer-originating acetate uptake through MCT1 in reactive astrocytes in the glioblastoma tumor microenvironment. Neuro Oncol. 2023. https://doi.org/10.1093/neuonc/noad243. – reference: Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 2015;17 Suppl 4:iv1-iv62. – reference: OmuroAMLeiteCCMokhtariKDelattreJYPitfalls in the diagnosis of brain tumoursLancet Neurol200659379481705266110.1016/S1474-4422(06)70597-X – reference: FerdovaEFerdaJBaxaJTupyRMracekJTopolcanOAssessment of grading in newly-diagnosed glioma using 18F-fluorothymidine PET/CTAnticancer Res2015359559591:CAS:528:DC%2BC2MXlslKrtrk%3D25667480 – reference: KimSKimDKimSHParkMAChangJHYunMThe roles of (11)C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral gliomaEur J Nucl Med Mol Imaging201845101210202951183810.1007/s00259-018-3948-9 – reference: NowosielskiMDiFrancoMDPutzerDSeizMRecheisWJacobsAHAn intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomasPLoS ONE2014924759867399748410.1371/journal.pone.0095830 – reference: ChenWSilvermanDHDelaloyeSCzerninJKamdarNPopeW18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracyJ Nucl Med2006479049111:CAS:528:DC%2BD28XmtlWmsbY%3D16741298 – reference: YamamotoYNishiyamaYKimuraNKameyamaRKawaiNHatakeyamaT11C-Acetate PET in the evaluation of brain glioma: comparison with 11C-methionine and 18F-FDG-PETMol Imaging Biol2008102812871:STN:280:DC%2BD1cvpvVygtQ%3D%3D1854304110.1007/s11307-008-0152-5 – reference: LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWKThe 2016 World Health Organization classification of tumors of the central nervous system: a summaryActa Neuropathol20161318038202715793110.1007/s00401-016-1545-1 – reference: PiccardoAAlbertNLBorgwardtLFaheyFHHargraveDGalldiksNJoint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0Eur J Nucl Med Mol Imaging.20224938526935536420939921110.1007/s00259-022-05817-6 – reference: Falk DelgadoAFalkDADiscrimination between primary low-grade and high-grade glioma with (11)C-methionine PET: a bivariate diagnostic test accuracy meta-analysisBr J Radiol2018912017042629206062596577510.1259/bjr.20170426 – reference: TripathiMSharmaRD'SouzaMJaiminiAPanwarPVarshneyRComparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomasClin Nucl Med2009348788832013982110.1097/RLU.0b013e3181becfe0 – reference: GronroosTBentzenLMarjamakiPMurataRHorsmanMRKeidingSComparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinomaEur J Nucl Med Mol Imaging2004315135201472267510.1007/s00259-003-1404-x – reference: ZaragoriTGinetMMariePYRochVGrignonRGauchotteGUse of static and dynamic [(18)F]-F-DOPA PET parameters for detecting patients with glioma recurrence or progressionEJNMMI Res2020105632472232726033110.1186/s13550-020-00645-x – reference: SmithTAThe rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporationNucl Med Biol200128141:CAS:528:DC%2BD3MXht1yjs7s%3D1118255810.1016/S0969-8051(00)00177-3 – reference: StoberBTanaseUHerzMSeidlCSchwaigerMSenekowitsch-SchmidtkeRDifferentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cellsEur J Nucl Med Mol Imaging2006339329391660434610.1007/s00259-005-0047-5 – reference: BarthelHCleijMCCollingridgeDRHutchinsonOCOsmanSHeQ3′-Deoxy-3′-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomographyCancer Res200363379137981:CAS:528:DC%2BD3sXltVGqs78%3D12839975 – reference: ColletSGuillamoJSBerroDHChakhoyanAConstansJMLechapt-ZalcmanESimultaneous mapping of vasculature, hypoxia, and proliferation using dynamic susceptibility contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in relation to contrast enhancement in newly diagnosed glioblastomaJ Nucl Med202162134913561:CAS:528:DC%2BB3MXisFamurfE34016725872490310.2967/jnumed.120.249524 – reference: ChenJRYaoYXuHZQinZYIsocitrate dehydrogenase (IDH)1/2 mutations as prognostic markers in patients with glioblastomasMedicine (Baltimore)2016951:CAS:528:DC%2BC28XktVOiu78%3D2694534910.1097/MD.0000000000002583 – reference: BagAKWingMNSabinNDHwangSNArmstrongGTHanY(11)C-Methionine PET for identification of pediatric high-grade glioma recurrenceJ Nucl Med2022636646711:CAS:528:DC%2BB38XisVyqtr7M344464539051591 – reference: DemetriadesAKAlmeidaACBhangooRSBarringtonSFApplications of positron emission tomography in neuro-oncology: a clinical approachSurgeon2014121481572462984110.1016/j.surge.2013.12.001 – reference: SalberDStoffelsGPauleitDOros-PeusquensAMShahNJKlauthPDifferential uptake of O-(2–18F-fluoroethyl)-L-tyrosine, L-3H-methionine, and 3H-deoxyglucose in brain abscessesJ Nucl Med200748205620621:CAS:528:DC%2BD1cXnvFSmug%3D%3D1800661210.2967/jnumed.107.046615 – reference: HoCLYuSCYeungDW11C-Acetate PET imaging in hepatocellular carcinoma and other liver massesJ Nucl Med20034421322112571212 – reference: ChapmanJDFrankoAJSharplinJA marker for hypoxic cells in tumours with potential clinical applicabilityBr J Cancer1981435465501:CAS:528:DyaL3MXkslKgtLs%3D7236492201062710.1038/bjc.1981.79 – reference: Di ChiroGDeLaPazRLBrooksRASokoloffLKornblithPLSmithBHGlucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomographyNeurology19823213231329698304410.1212/WNL.32.12.1323 – reference: OyamaNAkinoHKanamaruHSuzukiYMuramotoSYonekuraY11C-Acetate PET imaging of prostate cancerJ Nucl Med2002431811861:CAS:528:DC%2BD38XjvFWjtro%3D11850482 – reference: Skoblar Vidmar M, Doma A, Smrdel U, Zevnik K, Studen A. The value of FET PET/CT in recurrent glioma with a different IDH mutation status: the relationship between imaging and molecular biomarkers. Int J Mol Sci. 2022;23:6787. – reference: KinoshitaMAritaHGotoTOkitaYIsohashiKWatabeTA novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltrationJ Nucl Med201253170117082300074710.2967/jnumed.112.104992 – reference: HeoJYNamMHYoonHHKimJHwangYJWonWAberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinson’s diseaseCurr Biol202030276–91 – reference: LiuRSChangCPChuLSChuYKHsiehHJChangCWPET imaging of brain astrocytoma with 1–11C-acetateEur J Nucl Med Mol Imaging2006334204271640459610.1007/s00259-005-0023-0 – reference: VesselleHGriersonJMuziMPugsleyJMSchmidtRARabinowitzPIn vivo validation of 3′deoxy-3′-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumorsClin Cancer Res20028331533231:CAS:528:DC%2BD38XpsVCgtr0%3D12429617 – reference: KimDChoAHwangSHJoKChangJHYunMChoroid plexus as the best reference region for standardized uptake value analysis on C11-acetate PET/CT for grading and predicting prognosis in patients with cerebral gliomasNucl Med Mol Imaging2020542742801:CAS:528:DC%2BB3cXisVOltr7O33281998770482110.1007/s13139-020-00672-5 – reference: JagerPLVaalburgWPruimJde VriesEGLangenKJPiersDARadiolabeled amino acids: basic aspects and clinical applications in oncologyJ Nucl Med2001424324451:CAS:528:DC%2BD3MXmvFOqt7k%3D11337520 – reference: LouisDNPerryAWesselingPBratDJCreeIAFigarella-BrangerDThe 2021 WHO classification of tumors of the central nervous system: a summaryNeuro Oncol202123123112511:CAS:528:DC%2BB3MXisFSht73J34185076832801310.1093/neuonc/noab106 – reference: KimDChunJHYiJHKoHYChungJILeeM11 C-Acetate PET/CT detects reactive astrogliosis helping glioma classificationClin Nucl Med2022478638683586800210.1097/RLU.0000000000004341 – reference: GuedjEVarroneABoellaardRAlbertNLBarthelHvan BerckelBEANM procedure guidelines for brain PET imaging using [(18)F]FDG, version 3Eur J Nucl Med Mol Imaging2022496326513488226110.1007/s00259-021-05603-w – reference: Reuss AM, Groos D, Buchfelder M, Savaskan N. The acidic brain-glycolytic switch in the microenvironment of malignant glioma. Int J Mol Sci. 2021;22:5518. – reference: BuschHDavisJRHonigGRAndersonDCNairPVNyhanWLThe uptake of a variety of amino acids into nuclear proteins of tumors and other tissuesCancer Res195919103010391:CAS:528:DyaF3cXhvValug%3D%3D13806375 – reference: JerabekPAPatrickTBKilbournMRDischinoDDWelchMJSynthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissueInt J Rad Appl Instrum A1986375996051:CAS:528:DyaL28Xls1Sntrk%3D302166210.1016/0883-2889(86)90079-1 – reference: EidelbergDTakikawaSDhawanVChalyTRobesonWDahlRStriatal 18F-dopa uptake: absence of an aging effectJ Cereb Blood Flow Metab1993138818881:CAS:528:DyaK2cXhtVSkurs%3D836029410.1038/jcbfm.1993.110 – reference: TakataKKatoHShimosegawaEOkunoTKodaTSugimotoT11C-Acetate PET imaging in patients with multiple sclerosisPLoS ONE2014925369426421972510.1371/journal.pone.0111598 – reference: MasuiKCaveneeWKMischelPSmTORC2 and metabolic reprogramming in GBM: at the interface of genetics and environmentBrain Pathol2015257557591:CAS:528:DC%2BC2MXhvVSlsLbM26526943463601610.1111/bpa.12307 – reference: BrownJMTherapeutic targets in radiotherapyInt J Radiat Oncol Biol Phys2001493193261:STN:280:DC%2BD3M7kvFGlsw%3D%3D1117312410.1016/S0360-3016(00)01482-6 – reference: LawIAlbertNLArbizuJBoellaardRDrzezgaAGalldiksNJoint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0Eur J Nucl Med Mol Imaging.201946540571:CAS:528:DC%2BC1cXisVKrt7bE3051986710.1007/s00259-018-4207-9 – reference: ChungJKKimYKKimSKLeeYJPaekSYeoJSUsefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PETEur J Nucl Med Mol Imaging2002291761821:CAS:528:DC%2BD38XnvFSmtg%3D%3D1192637910.1007/s00259-001-0690-4 – reference: BarajasRFJrPampaloniMHClarkeJLSeoYSavicDHawkinsRAAssessing biological response to bevacizumab using 18F-fluoromisonidazole PET/MR imaging in a patient with recurrent anaplastic astrocytomaCase Rep Radiol20152015257931364352456 – reference: SinghalTNarayananTKJacobsMPBalCMantilJC11C-Methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRIJ Nucl Med201253170917152305553410.2967/jnumed.111.102533 – reference: CruzNFLasaterAZielkeHRDienelGAActivation of astrocytes in brain of conscious rats during acoustic stimulation: acetate utilization in working brainJ Neurochem2005929349471:CAS:528:DC%2BD2MXhs1Kqtbs%3D1568649610.1111/j.1471-4159.2004.02935.x – reference: GlaudemansAWEntingRHHeestersMADierckxRAvan RheenenRWWalenkampAMValue of 11C-methionine PET in imaging brain tumours and metastasesEur J Nucl Med Mol Imaging2013406156351:CAS:528:DC%2BC3sXjslOgsbs%3D2323250510.1007/s00259-012-2295-5 – reference: NamMHKoHYKimDLeeSParkYMHyeonSJVisualizing reactive astrocyte-neuron interaction in Alzheimer’s disease using 11C-acetate and 18F-FDGBrain202314629572974370625411051719510.1093/brain/awad037 – reference: MashimoTPichumaniKVemireddyVHatanpaaKJSinghDKSirasanagandlaSAcetate is a bioenergetic substrate for human glioblastoma and brain metastasesCell2014159160316141:CAS:528:DC%2BC2MXnslKqug%3D%3D25525878437460210.1016/j.cell.2014.11.025 – reference: JohnsonJMChenMMRohrenEMPrabhuSChasenBMawlawiODelayed FDG PET provides superior glioblastoma conspicuity compared to conventional image timingFront Neurol20211234867723863511010.3389/fneur.2021.740280 – reference: WalshJCLebedevAAtenEMadsenKMarcianoLKolbHCThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesAntioxid Redox Signal201421151615541:CAS:528:DC%2BC2cXhsFamsrjF24512032415993710.1089/ars.2013.5378 – reference: MiyagawaTOkuTUeharaHDesaiRBeattieBTjuvajevJ“Facilitated” amino acid transport is upregulated in brain tumorsJ Cereb Blood Flow Metab1998185005091:CAS:528:DyaK1cXjsVWitrg%3D959184210.1097/00004647-199805000-00005 – reference: JoSYarishkinOHwangYJChunYEParkMWooDHGABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s diseaseNat Med2014208868961:CAS:528:DC%2BC2cXhtVKlsrfP24973918838545210.1038/nm.3639 – reference: Hirata K, Yamaguchi S, Shiga T, Kuge Y, Tamaki N. The roles of hypoxia imaging using (18)F-fluoromisonidazole positron emission tomography in glioma treatment. J Clin Med. 2019;8:1088. – reference: LauEWDrummondKJWareREDrummondEHoggARyanGComparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumourJ Clin Neurosci20101743492000458210.1016/j.jocn.2009.05.009 – reference: YoulandRSKitangeGJPetersonTEPafundiDHRamiscalJAPokornyJLThe role of LAT1 in (18)F-DOPA uptake in malignant gliomasJ Neurooncol201311111181:CAS:528:DC%2BC38XhvFSgtLjP2308643110.1007/s11060-012-0986-1 – reference: MatsubaraKWatabeHKumakuraYHayashiTEndresCJMinatoKSensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [(1)(8)F]FDOPA PET by a model with detailed dopamine pathwaySynapse2011657517621:CAS:528:DC%2BC3MXmvFWhtrk%3D2119022010.1002/syn.20899 – reference: ShinomiyaAKawaiNOkadaMMiyakeKNakamuraTKushidaYEvaluation of 3′-deoxy-3′-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomasEur J Nucl Med Mol Imaging2013401751851:CAS:528:DC%2BC3sXkvVKrtw%3D%3D2322974610.1007/s00259-012-2275-9 – reference: WesterHJHerzMWeberWHeissPSenekowitsch-SchmidtkeRSchwaigerMSynthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imagingJ Nucl Med1999402052121:CAS:528:DyaK1MXos1aitA%3D%3D9935078 – reference: PikeVWEakinsMNAllanRMSelwynAPPreparation of [1-11C]acetate–an agent for the study of myocardial metabolism by positron emission tomographyInt J Appl Radiat Isot1982335055121:CAS:528:DyaL38XltFGgsrs%3D698160610.1016/0020-708X(82)90003-5 – reference: HammondEMAsselinMCForsterDO'ConnorJPSenraJMWilliamsKJThe meaning, measurement and modification of hypoxia in the laboratory and the clinicClin Oncol (R Coll Radiol)2014262772881:STN:280:DC%2BC2crhtlCruw%3D%3D2460256210.1016/j.clon.2014.02.002 – volume: 32 start-page: 1323 year: 1982 ident: 847_CR15 publication-title: Neurology doi: 10.1212/WNL.32.12.1323 – volume: 190 start-page: W365 year: 2008 ident: 847_CR7 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.07.2660 – volume: 95 year: 2016 ident: 847_CR24 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000002583 – volume: 9 year: 2014 ident: 847_CR65 publication-title: PLoS ONE doi: 10.1371/journal.pone.0111598 – volume: 37 start-page: 599 year: 1986 ident: 847_CR94 publication-title: Int J Rad Appl Instrum A doi: 10.1016/0883-2889(86)90079-1 – volume: 35 start-page: 955 year: 2015 ident: 847_CR88 publication-title: Anticancer Res – volume: 40 start-page: 175 year: 2013 ident: 847_CR86 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2275-9 – volume: 43 start-page: 181 year: 2002 ident: 847_CR67 publication-title: J Nucl Med – volume: 36 start-page: 422 year: 2009 ident: 847_CR68 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-008-0981-0 – ident: 847_CR1 doi: 10.1093/neuonc/nov189 – volume: 10 start-page: 281 year: 2008 ident: 847_CR73 publication-title: Mol Imaging Biol doi: 10.1007/s11307-008-0152-5 – volume: 21 start-page: 1516 year: 2014 ident: 847_CR89 publication-title: Antioxid Redox Signal doi: 10.1089/ars.2013.5378 – volume: 27 start-page: 71 year: 2023 ident: 847_CR79 publication-title: Biomater Res doi: 10.1186/s40824-023-00408-4 – volume: 65 start-page: 751 year: 2011 ident: 847_CR45 publication-title: Synapse doi: 10.1002/syn.20899 – volume: 49 start-page: 3852 year: 2022 ident: 847_CR13 publication-title: Eur J Nucl Med Mol Imaging. doi: 10.1007/s00259-022-05817-6 – volume: 26 start-page: 277 year: 2014 ident: 847_CR92 publication-title: Clin Oncol (R Coll Radiol) doi: 10.1016/j.clon.2014.02.002 – volume: 43 start-page: 311 year: 2018 ident: 847_CR8 publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000002006 – volume: 33 start-page: 932 year: 2006 ident: 847_CR42 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0047-5 – volume: 33 start-page: 505 year: 1982 ident: 847_CR52 publication-title: Int J Appl Radiat Isot doi: 10.1016/0020-708X(82)90003-5 – ident: 847_CR97 doi: 10.3390/ijms22115518 – volume: 104 start-page: 125 year: 2002 ident: 847_CR63 publication-title: Clin Neurol Neurosurg doi: 10.1016/S0303-8467(01)00197-4 – volume: 43 start-page: 546 year: 1981 ident: 847_CR93 publication-title: Br J Cancer doi: 10.1038/bjc.1981.79 – volume: 40 start-page: 205 year: 1999 ident: 847_CR40 publication-title: J Nucl Med – volume: 34 start-page: 878 year: 2009 ident: 847_CR85 publication-title: Clin Nucl Med doi: 10.1097/RLU.0b013e3181becfe0 – volume: 49 start-page: 319 year: 2001 ident: 847_CR90 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(00)01482-6 – volume: 146 start-page: 2957 year: 2023 ident: 847_CR64 publication-title: Brain doi: 10.1093/brain/awad037 – volume: 63 start-page: 664 year: 2022 ident: 847_CR37 publication-title: J Nucl Med – volume: 48 start-page: 2056 year: 2007 ident: 847_CR41 publication-title: J Nucl Med doi: 10.2967/jnumed.107.046615 – volume: 14 start-page: 1473 year: 2012 ident: 847_CR49 publication-title: Neuro Oncol doi: 10.1093/neuonc/nos259 – volume: 10 start-page: 56 year: 2020 ident: 847_CR48 publication-title: EJNMMI Res doi: 10.1186/s13550-020-00645-x – volume: 25 start-page: 755 year: 2015 ident: 847_CR71 publication-title: Brain Pathol doi: 10.1111/bpa.12307 – volume: 42 start-page: 432 year: 2001 ident: 847_CR25 publication-title: J Nucl Med – volume: 53 start-page: 1709 year: 2012 ident: 847_CR4 publication-title: J Nucl Med doi: 10.2967/jnumed.111.102533 – volume: 18 start-page: 426 year: 2016 ident: 847_CR43 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov148 – volume: 31 start-page: 1668 year: 2011 ident: 847_CR56 publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2011.84 – volume: 23 start-page: 1555 year: 2020 ident: 847_CR60 publication-title: Nat Neurosci doi: 10.1038/s41593-020-00735-y – volume: 47 start-page: 904 year: 2006 ident: 847_CR30 publication-title: J Nucl Med – volume: 265 start-page: 12916 year: 1990 ident: 847_CR57 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)38247-X – volume: 33 start-page: 16 year: 2014 ident: 847_CR6 publication-title: Chin J Cancer doi: 10.5732/cjc.013.10217 – volume: 49 start-page: 632 year: 2022 ident: 847_CR14 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05603-w – volume: 40 start-page: 1367 year: 1999 ident: 847_CR39 publication-title: J Nucl Med – ident: 847_CR5 doi: 10.3413/Nukmed-0662-14-04 – volume: 10 start-page: 453 year: 2011 ident: 847_CR34 publication-title: Mol Imaging doi: 10.2310/7290.2011.00014 – volume: 13 start-page: 4943 year: 2023 ident: 847_CR11 publication-title: Quant Imaging Med Surg doi: 10.21037/qims-22-1340 – volume: 28 start-page: 1 year: 2001 ident: 847_CR16 publication-title: Nucl Med Biol doi: 10.1016/S0969-8051(00)00177-3 – volume: 131 start-page: 803 year: 2016 ident: 847_CR2 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 – volume: 16 start-page: 549 year: 1969 ident: 847_CR53 publication-title: J Neurochem doi: 10.1111/j.1471-4159.1969.tb06854.x – volume: 37 start-page: 429 year: 2007 ident: 847_CR81 publication-title: Semin Nucl Med doi: 10.1053/j.semnuclmed.2007.08.001 – volume: 18 start-page: 500 year: 1998 ident: 847_CR28 publication-title: J Cereb Blood Flow Metab doi: 10.1097/00004647-199805000-00005 – volume: 116 start-page: 597 year: 2008 ident: 847_CR23 publication-title: Acta Neuropathol doi: 10.1007/s00401-008-0455-2 – ident: 847_CR77 doi: 10.1093/neuonc/noad243 – volume: 53 start-page: 1701 year: 2012 ident: 847_CR29 publication-title: J Nucl Med doi: 10.2967/jnumed.112.104992 – volume: 45 start-page: 1012 year: 2018 ident: 847_CR75 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-018-3948-9 – volume: 32 year: 2020 ident: 847_CR62 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.107975 – volume: 9 year: 2014 ident: 847_CR87 publication-title: PLoS ONE doi: 10.1371/journal.pone.0095830 – volume: 12 year: 2021 ident: 847_CR20 publication-title: Front Neurol doi: 10.3389/fneur.2021.740280 – volume: 64 start-page: 2773 year: 1995 ident: 847_CR58 publication-title: J Neurochem doi: 10.1046/j.1471-4159.1995.64062773.x – volume: 46 start-page: 1678 year: 2019 ident: 847_CR50 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-019-04337-0 – volume: 54 start-page: 274 year: 2020 ident: 847_CR76 publication-title: Nucl Med Mol Imaging doi: 10.1007/s13139-020-00672-5 – volume: 12 start-page: 148 year: 2014 ident: 847_CR18 publication-title: Surgeon doi: 10.1016/j.surge.2013.12.001 – volume: 13 start-page: 881 year: 1993 ident: 847_CR46 publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.1993.110 – volume: 7 start-page: 656 year: 2020 ident: 847_CR51 publication-title: Neurooncol Pract – volume: 44 start-page: 213 year: 2003 ident: 847_CR69 publication-title: J Nucl Med – ident: 847_CR10 doi: 10.3390/ijms20194669 – volume: 159 start-page: 1603 year: 2014 ident: 847_CR70 publication-title: Cell doi: 10.1016/j.cell.2014.11.025 – ident: 847_CR19 doi: 10.3390/cancers12071977 – volume: 111 start-page: 11 year: 2013 ident: 847_CR47 publication-title: J Neurooncol doi: 10.1007/s11060-012-0986-1 – volume: 20 start-page: 886 year: 2014 ident: 847_CR59 publication-title: Nat Med doi: 10.1038/nm.3639 – volume: 23 start-page: 1231 year: 2021 ident: 847_CR3 publication-title: Neuro Oncol doi: 10.1093/neuonc/noab106 – volume: 47 start-page: 863 year: 2022 ident: 847_CR78 publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000004341 – ident: 847_CR36 doi: 10.3390/cancers13194777 – volume: 29 start-page: 176 year: 2002 ident: 847_CR32 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-001-0690-4 – volume: 62 start-page: 1349 year: 2021 ident: 847_CR96 publication-title: J Nucl Med doi: 10.2967/jnumed.120.249524 – volume: 17 start-page: 43 year: 2010 ident: 847_CR31 publication-title: J Clin Neurosci doi: 10.1016/j.jocn.2009.05.009 – volume: 324 start-page: 192 year: 2009 ident: 847_CR22 publication-title: Science doi: 10.1126/science.1173362 – volume: 33 start-page: 420 year: 2006 ident: 847_CR72 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0023-0 – volume: 53 start-page: 1904 year: 2012 ident: 847_CR82 publication-title: J Nucl Med doi: 10.2967/jnumed.112.105544 – volume: 41 start-page: 369 year: 2021 ident: 847_CR66 publication-title: J Cereb Blood Flow Metab doi: 10.1177/0271678X20911469 – volume: 46 start-page: 540 year: 2019 ident: 847_CR12 publication-title: Eur J Nucl Med Mol Imaging. doi: 10.1007/s00259-018-4207-9 – volume: 5 start-page: 937 year: 2006 ident: 847_CR17 publication-title: Lancet Neurol doi: 10.1016/S1474-4422(06)70597-X – volume: 18 start-page: 5225 year: 1998 ident: 847_CR54 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.18-14-05225.1998 – volume: 63 start-page: 3791 year: 2003 ident: 847_CR80 publication-title: Cancer Res – volume: 286 start-page: 929 year: 1972 ident: 847_CR26 publication-title: N Engl J Med doi: 10.1056/NEJM197204272861707 – volume: 8 start-page: 3315 year: 2002 ident: 847_CR84 publication-title: Clin Cancer Res – ident: 847_CR91 doi: 10.3390/jcm8081088 – volume: 91 start-page: 20170426 year: 2018 ident: 847_CR35 publication-title: Br J Radiol doi: 10.1259/bjr.20170426 – volume: 2015 year: 2015 ident: 847_CR98 publication-title: Case Rep Radiol – volume: 19 start-page: 1030 year: 1959 ident: 847_CR27 publication-title: Cancer Res – volume: 92 start-page: 934 year: 2005 ident: 847_CR55 publication-title: J Neurochem doi: 10.1111/j.1471-4159.2004.02935.x – volume: 12 year: 2021 ident: 847_CR9 publication-title: Front Neurol doi: 10.3389/fneur.2021.671867 – volume: 30 issue: 276–91 year: 2020 ident: 847_CR61 publication-title: Curr Biol – volume: 54 start-page: 903 year: 2013 ident: 847_CR83 publication-title: J Nucl Med doi: 10.2967/jnumed.112.112201 – volume: 24 start-page: 1546 year: 2022 ident: 847_CR38 publication-title: Neuro Oncol doi: 10.1093/neuonc/noac040 – volume: 35 start-page: 171 year: 2008 ident: 847_CR74 publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2007.11.004 – volume: 32 start-page: 1185 year: 2002 ident: 847_CR21 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(02)00815-8 – volume: 40 start-page: 615 year: 2013 ident: 847_CR33 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2295-5 – ident: 847_CR44 doi: 10.3390/ijms23126787 – volume: 31 start-page: 513 year: 2004 ident: 847_CR95 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-003-1404-x – reference: 39881977 - Nucl Med Mol Imaging. 2025 Feb;59(1):91. doi: 10.1007/s13139-024-00879-w |
| SSID | ssj0000329037 |
| Score | 2.3458104 |
| SecondaryResourceType | review_article |
| Snippet | Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive glioma evaluation, offering complementary... Positron emission tomography/computed tomography (PET/CT) has dramatically altered the landscape of noninvasive gliomaevaluation, offering complementary... |
| SourceID | nrf pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 237 |
| SubjectTerms | Amino acids Cardiology Computed tomography Imaging Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Nuclear Medicine Oncology Orthopedics Positron emission Radioactive tracers Radiology Review 방사선과학 |
| Title | Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma |
| URI | https://link.springer.com/article/10.1007/s13139-024-00847-4 https://www.ncbi.nlm.nih.gov/pubmed/38932755 https://www.proquest.com/docview/3071987805 https://www.proquest.com/docview/3072815093 https://pubmed.ncbi.nlm.nih.gov/PMC11196511 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003107671 |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Nuclear Medicine and Molecular Imaging , 2024, 58(4), , pp.237-245 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFH-inYS48P0RGJUR3MCjSZzEvtFF6zYQE0KNNE5W_BGo2iVT117463l2k1YdA2mX5OBn69l-z_7Zz_4Z4N2wihJrbUljJjRliIhwHBQVVYlgTAuujPKnLc7Sk4J9Pk_O20thV91p9y4k6Ufq7WW3GNEKxTmFOhL4jLIe7CUhF7wPe6PjH1-2eyvDOBJDT5fpHlxCNTLW3pe5uaCdOalXL6qb4ObfpyavhU79jDR-AEVXl_VBlNnBaqkO9O9rNI-3rexDuN9CVDJa29QjuGPrx3D3axuEfwKfEGqicqS4dLsFpKnJt6PJx3xCvpdm2qDSGiElQTBMTi_8G0gktwsXn56T4_m0uSifQjE-muQntH2IgWp02SVVnFkuNK7O0kxHxoRp5e7HlYjdhKmEQtRXpZkQVghmKwQoYajSlDuiKcszU8bPoF83tX0BxJSJNkalmM-gLZQqs1VWhZozR10Y8gDCriukblnK3WMZc7nlV3ZNI7FppG8ayQJ4v8lzuebo-K_0W-xhOdNT6ai13f9nI2cLiQuIU8yU4AgWxgHsdxYgW6--kjgeuj0aPkwCeLNJRn90QZayts3Ky2C9EYZhEc_XBrNRyoHDKEswN98xpY2AU2g3pZ7-8pzfOCWJFMFxAB86g9nq9e_Kvryd-Cu4F3mbc7tM-9BfLlb2NYKupRqgj40PD88Gra8NoJenOX6LaPQHnpMhKA |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxMxEB61qQRcaHkUlhYwghu47MO7a9-oorYJfQihRCona_2CKOlulSYXfj3jzW6ilILU0x7Wtsb2jP15xv4G4EPo4tRaW9CECU0ZIiJcB4WjKhWMacGVUfVti4usN2RfL9PL5lHYTXvbvQ1J1iv16rFbgmiF4p5CPQl8TtkmbDE8g4cd2Do8-XG68q2ESSzCmi7TJ1xCMXLWvJe5u6G1PWmznLq74ObftyZvhU7rHel4G4ZtXxYXUcYH85k60L9v0Tzet7M78LiBqORwoVNPYMOWT-HBeROEfwZfEGqicGR47b0FpCrJt6PB5-6AfC_MqEKhNUJKgmCY9K_qHEika6c-Pj0hJ5NRdVU8h-Hx0aDbo00iBqrRZGdUcWa50Hg6y3IdGxNlzr-PKxC7CeOEQtTnslwIKwSzDgFKFKks455oyvLcFMkudMqqtC-BmCLVxqgM6xnUhULl1uUu0px56sKIBxC1UyF1w1Luk2VM5Ipf2Q-NxKGR9dBIFsDHZZ3rBUfHf0u_xxmWYz2Snlrbf39WcjyVeIDoY6UUV7AoCWC_1QDZWPWNxPXQ-2h4mAbwbvkb7dEHWYrSVvO6DPYbYRg28WKhMEuhPDiM8xRr8zVVWhbwAq3_KUe_as5v3JJEhuA4gE-twqzk-ndnX92v-Ft42Bucn8mz_sXpHjyKa_3zHqd96Mymc_saAdhMvWns7Q-B6SDD |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED-xIU28TIzPwAZG8AZRm8RJ7DemsrLyMU2olfZmxV-sWpdUpfv_uXPTlMJA4ilS7LNs39n-2ef7GeBN36e5c66KMy5NzBER4TwofaxzybmRQlsdblucFacT_ukiv_glij_cdl-7JFcxDcTSVC97c-t7m8C3DJFLjOtLTITwZcx34C6nn2jRk_S4O2XpZ6nsB-JMenoJK1TyNnLm9mK2VqedeuFvA55_3p_8zYka1qbhfdhvQSU7XlnBAdxx9QPY-9q6zR_CewSHWAibzGl_z5qanZ-Me4Mx-1bZaYOFGwSBDOErG12HV4vYwC3IozxjH2fT5rp6BJPhyXhwGrdPJ8QGB9ky1oI7IQ3up4rSpNYmhaeItgrRlrReasRpviildFJy5xFSJIkuCkHUUE6Utsoew27d1O4pMFvlxlpdoJxF7VW6dL70iRGcyAYTEUGy7jJlWl5xet5ipjaMyNTNCrtZhW5WPIK3ncx8xarxz9yvURPqykwVkWHT93ujrhYKIf8IhXKcc5IsgsO1plQ7Dn8onMHoVEX08whedck4gsgtUtWuuQl5sN0InLCIJyvFdpUiOJeWOUqLLZV3GahC2yn19DKwdOMiIguEsxG8W1vHpl5_b-yz_8v-EvbOPwzVl9HZ5-dwLw2mTEdEh7C7XNy4I0RMS_0iDIqfmFYICQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+Update+on+PET%2FCT+Radiotracers+for+Imaging+Cerebral+Glioma&rft.jtitle=Nuclear+medicine+and+molecular+imaging&rft.au=Kim%2C+Dongwoo&rft.au=Lee%2C+Suk-Hyun&rft.au=Hwang%2C+Hee+Sung&rft.au=Kim%2C+Sun+Jung&rft.date=2024-06-01&rft.issn=1869-3474&rft.eissn=1869-3482&rft.volume=58&rft.issue=4&rft.spage=237&rft.epage=245&rft_id=info:doi/10.1007%2Fs13139-024-00847-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s13139_024_00847_4 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1869-3474&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1869-3474&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1869-3474&client=summon |